InvestorsHub Logo
Followers 0
Posts 6
Boards Moderated 0
Alias Born 05/02/2017

Re: None

Thursday, 04/14/2022 1:15:57 PM

Thursday, April 14, 2022 1:15:57 PM

Post# of 43812
We know all the facts, Trial proved very significant 14.1% OS for the predestinated non chemo patient arm. MK is non toxic. So risk reward for patients is excellent and something the FDA will accept. There has not been any new treatment for H&N cancer in a half a century. MK is a great new treatment for this terrible disease. Something that can give hope and increased survival for approximately 210,000 patients world wide annually. I know the shorts and bashers would love for MK not to get approval so they could make a few bucks and brag how the screwed the longs. Very sad. That they could attack a small bio. That has worked tirelessly for numerous years to bring a life saving non toxic treatment. So patients can spend more time on this earth with their wives, kids, friends and family. They should be ashamed of themselves. .
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News